Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Receivables - Net (2020 - 2025)

Historic Receivables - Net for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $33.0 million.

  • Treace Medical Concepts' Receivables - Net rose 3632.38% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.0 million, marking a year-over-year increase of 3632.38%. This contributed to the annual value of $40.8 million for FY2024, which is 719.86% up from last year.
  • Latest data reveals that Treace Medical Concepts reported Receivables - Net of $33.0 million as of Q3 2025, which was up 3632.38% from $30.3 million recorded in Q2 2025.
  • Treace Medical Concepts' 5-year Receivables - Net high stood at $40.8 million for Q4 2024, and its period low was $10.0 million during Q2 2021.
  • For the 5-year period, Treace Medical Concepts' Receivables - Net averaged around $24.3 million, with its median value being $25.4 million (2023).
  • Its Receivables - Net has fluctuated over the past 5 years, first soared by 6503.24% in 2023, then tumbled by 614.35% in 2024.
  • Over the past 5 years, Treace Medical Concepts' Receivables - Net (Quarter) stood at $18.6 million in 2021, then soared by 57.24% to $29.2 million in 2022, then soared by 30.37% to $38.1 million in 2023, then grew by 7.2% to $40.8 million in 2024, then dropped by 19.22% to $33.0 million in 2025.
  • Its last three reported values are $33.0 million in Q3 2025, $30.3 million for Q2 2025, and $31.1 million during Q1 2025.